Uncertainty about future care and life impacts were among the top concerns for patients with psoriatic arthritis, but not for ...

Not a lot of people know about psoriasis which is why several myths and misconceptions about the condition continue to ...

The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.

A deeper understanding of the inflammatory processes driving psoriasis and psoriatic arthritis is translating into new research approaches that could potentially benefit patients. Psoriasis is a ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Hispanic and non-White patients with psoriatic arthritis (PsA) had higher tender joint counts and greater disease severity, highlighting racial and ethnic disparities in PsA disease burden and ...

Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal ...

Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.

ALEXANDRIA, VA, UNITED STATES, February 4, 2025 /EINPresswire / -- The National Psoriasis Foundation (NPF) is pleased to announce an anonymous gift o ...

A recent study reaffirmed the safety and effectiveness of guselkumab, in managing psoriasis and psoriatic arthritis over an extended period of 208 weeks (approximately 4 years). This ...